RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant chemotherapy

ObjectiveThe primary aim of this study is to investigate the relationship between the expression of the homologous recombination protein RAD51 and the CA125 elimination rate constant K (KELIM) score in the context of sensitivity to neoadjuvant chemotherapy (NACT) in patients with advanced high-grade...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Hui Liu, Yufang Xia, Yunqing Chen, Huiyang Qi, Huixiang Ji, Shujun Ji, Yanhui Lou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	RAD51 protein KELIM score high-grade serous ovarian cancer neoadjuvant chemotherapy chemotherapy sensitivity
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1548889/full